Moleculin Biotech, Inc. Other Current Assets
Moleculin Biotech, Inc. (MBRX) had Other Current Assets of $257.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2020-11-12
- 2020-09-30: Other Assets, Current $257.00K.
- 2020-06-30: Other Assets, Current $436.00K.
- 2020-03-31: Other Assets, Current $615.00K.
- 2019-12-31: Other Assets, Current $529.00K.
| Period end | Other Assets, Current |
|---|---|
| 2020-09-30 | $257.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $436.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $615.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $529.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |